We report voluntarily the information cited in this GRI content index for the reporting period with reference to the GRI Standards 2021. The following index provides an overview of all relevant GRI standards and shows the information on our company's sustainability that we consider to be material.
The GRI-disclosures were not part of the limited assurance engagement conducted by an independent auditor for our 2024 Combined Sustainability Statement.
General disclosures
GRI 2: General Disclosures 2021
| GRI Standard and Disclosure | Reference | |||
|
2-1 |
Organizational details |
|||
|
2-2 |
Entities included in the organization’s sustainability reporting |
|||
|
2-3 |
Reporting period, frequency and contact point |
|||
|
2-4 |
Restatements of information |
|||
|
2-5 |
External assurance |
|||
|
2-6 |
Activities, value chain and other business relationships |
Fundamental Information about the Group |
||
|
2-7 |
Employees |
|||
|
2-9 |
Governance structure and composition |
Statement on Corporate Governance |
||
|
2-10 |
Nomination and selection of the highest governance body |
Objectives of the Supervisory Board |
||
|
2-11 |
Chair of the highest governance body |
|||
|
2-12 |
Role of the highest governance body in overseeing the management of impacts |
Report of the Supervisory Board |
||
|
2-13 |
Delegation of responsibility for managing impacts |
|||
|
2-14 |
Role of the highest governance body in sustainability reporting |
|||
|
2-15 |
Conflicts of interest |
|||
|
2-17 |
Collective knowledge of the highest governance body |
|||
|
2-18 |
Evaluation of the performance of the highest governance body |
|||
|
2-19 |
Remuneration policies |
|||
|
2-20 |
Process to determine remuneration |
|||
|
2-22 |
Statement on sustainable development strategy |
|||
|
2-23 |
Policy commitments |
S4-1 (Health and safety of our patients) S4-1 (Access to our products and services and access to (quality) information) S4-4 (Access to our products and services and access to (quality) information) S4-4 (Access to our products and services and access to (quality) information) S4-4 (Access to our products and services and access to (quality) information) S4-4 (Access to our products and services and access to (quality) information) |
||
|
2-24 |
Embedding policy commitments |
|||
|
2-25 |
Processes to remediate negative impacts |
Report on Risks and Opportunities S4-1 (Health and safety of our patients) S4-1 (Access to our products and services and access to (quality) information) S4-3 (Health and safety of our patients) S4-4 (Health and safety of our patients) S4-4 (Access to our products and services and access to (quality) information) |
||
|
2-26 |
Mechanisms for seeking advice and raising concerns |
|||
|
2-27 |
Compliance with laws and regulations |
|||
|
2-28 |
Membership associations |
|||
|
2-29 |
Approach to stakeholder engagement |
S4-1 (Health and safety of our patients) S4-1 (Access to our products and services and access to (quality) information) |
||
|
2-30 |
Collective bargaining agreements |
|||
GRI 3: Material Topics 2021
| GRI Standard and Disclosure | Reference | |||
|
3-1 |
Process to determine material topics |
|||
|
3-2 |
List of material topics |
|||
Economic standards
GRI 201: Economic Performance 2016
| GRI Standard and Disclosure | Reference | |||
|
201: 3-3 |
Management of material topics |
Statement on Corporate Governance Report on Risks and Opportunities S4-2 (Health and safety of our patients) S4-2 (Access to our products and services and access to (quality) information) S4-4 (Health and safety of our patients) S4-4 (Access to our products and services and access to (quality) information) S4-5 (Health and safety of our patients) S4-5 (Access to our products and services and access to (quality) information) |
||
|
201-1 |
Direct economic value generated and distributed |
|||
|
201-2 |
Financial implications and other risks and opportunities due to climate change |
|||
|
201-3 |
Defined benefit plan obligations and other retirement plans |
|||
|
201-4 |
Financial assistance received from government |
|||
GRI 203: Indirect Economic Impacts 2016
| GRI Standard and Disclosure | Reference | |||
|
203: 3-3 |
Management of material topics |
S4-2 (Health and safety of our patients) S4-2 (Access to our products and services and access to (quality) information) S4-4 (Health and safety of our patients) S4-4 (Access to our products and services and access to (quality) information) S4-5 (Health and safety of our patients) S4-5 (Access to our products and services and access to (quality) information) |
||
|
203-2 |
Significant indirect economic impacts |
S4-4 (Health and safety of our patients) S4-4 (Access to our products and services and access to (quality) information) |
||
GRI 205: Anti-corruption 2016
| GRI Standard and Disclosure | Reference | |||
|
205: 3-3 |
Management of material topics |
|||
|
205-1 |
Operations assessed for risks related to corruption |
|||
|
205-2 |
Communication and training about anti-corruption policies and procedures |
|||
|
205-3 |
Confirmed incidents of corruption and actions taken |
|||
GRI 206: Anti-competitive Behavior 2016
| GRI Standard and Disclosure | Reference | |||
|
206-1 |
Legal actions for anti-competitive behavior, anti-trust, and monopoly practices |
|||
Environmental standards
GRI 301: Materials 2016
| GRI Standard and Disclosure | Reference | |||
|
301: 3-3 |
Management of material topics |
|||
|
301-1 |
Materials used by weight or volume |
|||
|
301-2 |
Recycled input materials used |
|||
|
301-3 |
Reclaimed products and their packaging materials |
|||
GRI 302: Energy 2016
| GRI Standard and Disclosure | Reference | |||
|
302: 3-3 |
Management of material topics |
|||
|
302-1 |
Energy consumption within the organization |
|||
|
302-3 |
Energy intensity |
|||
|
302-4 |
Reduction of energy consumption |
|||
|
302-5 |
Reductions in energy requirements of products and services |
|||
GRI 303:
| GRI Standard and Disclosure | Reference | |||
|
303: 3-3 |
Management of material topics |
|||
|
303-1 |
Interactions with water as a shared resource |
|||
|
303-3 |
Water withdrawal |
|||
GRI 304:
| GRI Standard and Disclosure | Reference | |||
|
304: 3-3 |
Management of material topics |
|||
|
304-1 |
Operational sites owned, leased, managed in, or adjacent to, protected areas and areas of high biodiversity value outside protected areas |
|||
|
304-3 |
Habitats protected or restored |
|||
GRI 305: Emissions 2016
| GRI Standard and Disclosure | Reference | |||
|
305: 3-3 |
Management of material topics |
E2-1 (Substances of concern and substances of very high concern) E2-2 (Substances of concern and substances of very high concern) E2-3 (Substances of concern and substances of very high concern) |
||
|
305-1 |
Direct (Scope 1) GHG emissions |
|||
|
305-2 |
Energy indirect (Scope 2) GHG emissions |
|||
|
305-3 |
Other indirect (Scope 3) GHG emissions |
|||
|
305-4 |
GHG emissions intensity |
|||
|
305-5 |
Reduction of GHG emissions |
|||
|
305-6 |
Emissions of ozone-depleting substances (ODS) |
E2-5 (Substances of concern and substances of very high concern) |
||
|
305-7 |
Nitrogen oxides (NOx), sulfur oxides (SOx), and other significant air emissions |
|||
GRI 306: Waste 2020
| GRI Standard and Disclosure | Reference | |||
|
306: 3-3 |
Management of material topics |
|||
|
306-1 |
Waste generation and significant waste-related impacts |
|||
|
306-2 |
Management of significant waste-related impacts |
|||
|
306-3 |
Waste generated |
|||
|
306-4 |
Waste diverted from disposal |
|||
|
306-5 |
Waste directed to disposal |
|||
GRI 306: Effluents and Waste 2016
| GRI Standard and Disclosure | Reference | |||
|
306-3 |
Significant spills |
E2-1 (Substances of concern and substances of very high concern) E2-2 (Substances of concern and substances of very high concern) E2-3 (Substances of concern and substances of very high concern) E2-5 (Substances of concern and substances of very high concern) |
||
Social standards
GRI 401: Employment 2016
| GRI Standard and Disclosure | Reference | |||
|
401: 3-3 |
Management of material topics |
|||
|
401-1 |
New employee hires and employee turnover |
|||
GRI 402: Labor/Management Relations 2016
| GRI Standard and Disclosure | Reference | |||
|
402: 3-3 |
Management of material topics |
|||
GRI 403: Occupational Health and Safety 2018
| GRI Standard and Disclosure | Reference | |||
|
403: 3-3 |
Management of material topics |
|||
|
403-1 |
Occupational health and safety management system |
|||
|
403-2 |
Hazard identification, risk assessment, and incident investigation |
|||
|
403-4 |
Worker participation, consultation, and communication on occupational health and safety |
|||
|
403-5 |
Worker training on occupational health and safety |
|||
|
403-6 |
Promotion of worker health |
|||
|
403-7 |
Prevention and mitigation of occupational health and safety impacts directly linked by business relationships |
|||
|
403-8 |
Workers covered by an occupational health and safety management system |
|||
|
403-9 |
Work-related injuries |
|||
|
403-10 |
Work-related ill health |
|||
GRI 404: Training and Education 2016
| GRI Standard and Disclosure | Reference | |||
|
404: 3-3 |
Management of material topics |
|||
|
404-2 |
Programs for upgrading employee skills and transition assistance programs |
|||
|
404-3 |
Percentage of employees receiving regular performance and career development reviews |
|||
GRI 405: Diversity and Equal Opportunity 2016
| GRI Standard and Disclosure | Reference | |||
|
405: 3-3 |
Management of material topics |
|||
|
405-1 |
Diversity of governance bodies and employees |
|||
|
405-2 |
Ratio of basic salary and remuneration of women to men |
|||
GRI 406: Non-discrimination 2016
| GRI Standard and Disclosure | Reference | |||
|
406: 3-3 |
Management of material topics |
S4-1 (Health and safety of our patients) S4-1 (Access to our products and services and access to (quality) information) S4-2 (Health and safety of our patients) S4-2 (Access to our products and services and access to (quality) information) S4-4 (Health and safety of our patients) S4-4 (Access to our products and services and access to (quality) information) S4-5 (Health and safety of our patients) S4-5 (Access to our products and services and access to (quality) information) |
||
|
406-1 |
Incidents of discrimination and corrective actions taken |
|||
GRI 407: Freedom of Association and Collective Bargaining 2016
| GRI Standard and Disclosure | Reference | |||
|
407: 3-3 |
Management of material topics |
|||
|
407-1 |
Operations and suppliers in which the right to freedom of association and collective bargaining may be at risk |
|||
GRI 408: Child Labor 2016
| GRI Standard and Disclosure | Reference | |||
|
408: 3-3 |
Management of material topics |
|||
|
408-1 |
Operations and suppliers at significant risk for incidents of child labor |
|||
GRI 409: Forced or Compulsory Labor 2016
| GRI Standard and Disclosure | Reference | |||
|
409: 3-3 |
Management of material topics |
|||
|
409-1 |
Operations and suppliers at significant risk for incidents of forced or compulsory labor |
|||
GRI 416: Customer Health and Safety 2016
GRI 417: Marketing and Labeling 2016
GRI 418: Customer Privacy 2016
Additional material topics
Clinical studies
| GRI Standard and Disclosure | Reference | |||
|
3-3 |
Management of material topics |
S4 SBM-3 (Health and safety of our patients) S4-1 (Health and safety of our patients) S4-2 (Health and safety of our patients) |
||
Animal welfare
| GRI Standard and Disclosure | Reference | |||
|
3-3 |
Management of material topics |
|||